Details:
CollPlant has granted Allergan Aesthetics worldwide exclusivity to use its plant-derived recombinant human collagen (rhCollagen) in combination with Allergan Aesthetics' proprietary technologies, for the production and commercialization of dermal and soft tissue fillers.
Lead Product(s): rhCollagen
Therapeutic Area: Dermatology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: Allergan Aesthetics
Deal Size: $103.0 million Upfront Cash: $14.0 million
Deal Type: Collaboration February 08, 2021